MiNK Therapeutics
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell INKT and other ETFs, options, and stocks.About INKT
MiNK Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in the discovery, development, and commercialization of allogeneic invariant natural killer T cell therapies to treat cancer and other immune mediated diseases. The company was founded in 2017 and is headquartered in New York, NY.
INKT Key Statistics
Stock Snapshot
As of today, MiNK Therapeutics(INKT) shares are valued at $12.03. The company's market cap stands at 56.52M, with a P/E ratio of -3.97.
On 2026-01-07, MiNK Therapeutics(INKT) stock traded between a low of $11.86 and a high of $12.18. Shares are currently priced at $12.03, which is +1.4% above the low and -1.2% below the high.
MiNK Therapeutics(INKT) shares are trading with a volume of 5.69K, against a daily average of 15.28K.
In the last year, MiNK Therapeutics(INKT) shares hit a 52-week high of $76.00 and a 52-week low of $4.56.
In the last year, MiNK Therapeutics(INKT) shares hit a 52-week high of $76.00 and a 52-week low of $4.56.
INKT News
Claim 70% Off TipRanks This Holiday Season An update from MiNK Therapeutics ( (INKT) ) is now available. On December 29, 2025, Robert Kadlec, MD, resigned fro...